Article
Accelerated long-term forgetting is a BACE1 inhibitor-reversible incipient cognitive phenotype in Alzheimer's disease model mice.
Neuropsychopharmacology reports - 1 Jun 2021
Ohno Masuo
Abstract excerpt
AIM: After the continued failure of β-secretase (BACE1) inhibitor clinical trials in prodromal as well as mild-to-moderate Alzheimer's disease (AD), they are shifting to further earlier or asymptomatic stages. The aim of this study is to explore a cognitive paradigm that allows us to more sensitively detect beneficial effects of BACE1 inhibitors in presymptomatic AD. METHODS: GRL-8234 (33.4 mg/kg, ip), a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
